310 related articles for article (PubMed ID: 26642367)
21. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
[TBL] [Abstract][Full Text] [Related]
22. Extracellular adenosine enhances the ability of PMNs to kill Streptococcus pneumoniae by inhibiting IL-10 production.
Siwapornchai N; Lee JN; Tchalla EYI; Bhalla M; Yeoh JH; Roggensack SE; Leong JM; Bou Ghanem EN
J Leukoc Biol; 2020 Sep; 108(3):867-882. PubMed ID: 32017200
[TBL] [Abstract][Full Text] [Related]
23. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice.
Montesinos MC; Takedachi M; Thompson LF; Wilder TF; Fernández P; Cronstein BN
Arthritis Rheum; 2007 May; 56(5):1440-5. PubMed ID: 17469101
[TBL] [Abstract][Full Text] [Related]
24. CD73 is associated with poor prognosis in HNSCC.
Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
[TBL] [Abstract][Full Text] [Related]
25. CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer.
Petruk N; Tuominen S; Åkerfelt M; Mattsson J; Sandholm J; Nees M; Yegutkin GG; Jukkola A; Tuomela J; Selander KS
Sci Rep; 2021 Mar; 11(1):6035. PubMed ID: 33727591
[TBL] [Abstract][Full Text] [Related]
26. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
Wang L; Fan J; Thompson LF; Zhang Y; Shin T; Curiel TJ; Zhang B
J Clin Invest; 2011 Jun; 121(6):2371-82. PubMed ID: 21537079
[TBL] [Abstract][Full Text] [Related]
27. Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response.
Koszalka P; Ozüyaman B; Huo Y; Zernecke A; Flögel U; Braun N; Buchheiser A; Decking UK; Smith ML; Sévigny J; Gear A; Weber AA; Molojavyi A; Ding Z; Weber C; Ley K; Zimmermann H; Gödecke A; Schrader J
Circ Res; 2004 Oct; 95(8):814-21. PubMed ID: 15358667
[TBL] [Abstract][Full Text] [Related]
28. Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
Grenz A; Zhang H; Eckle T; Mittelbronn M; Wehrmann M; Köhle C; Kloor D; Thompson LF; Osswald H; Eltzschig HK
J Am Soc Nephrol; 2007 Mar; 18(3):833-45. PubMed ID: 17267736
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.
Koszałka P; Pryszlak A; Gołuńska M; Kolasa J; Stasiłojć G; Składanowski AC; Bigda JJ
Oncol Rep; 2014 Feb; 31(2):819-27. PubMed ID: 24297662
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.
Stagg J; Divisekera U; McLaughlin N; Sharkey J; Pommey S; Denoyer D; Dwyer KM; Smyth MJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1547-52. PubMed ID: 20080644
[TBL] [Abstract][Full Text] [Related]
31. CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A
Yan A; Joachims ML; Thompson LF; Miller AD; Canoll PD; Bynoe MS
J Neurosci; 2019 May; 39(22):4387-4402. PubMed ID: 30926752
[TBL] [Abstract][Full Text] [Related]
32. CD73/ecto-5'-nucleotidase protects against vascular inflammation and neointima formation.
Zernecke A; Bidzhekov K; Ozüyaman B; Fraemohs L; Liehn EA; Lüscher-Firzlaff JM; Lüscher B; Schrader J; Weber C
Circulation; 2006 May; 113(17):2120-7. PubMed ID: 16636171
[TBL] [Abstract][Full Text] [Related]
33. CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth, angiogenesis, neovascularization, macrophage infiltration and metastasis.
Koszałka P; Gołuńska M; Stanisławowski M; Urban A; Stasiłojć G; Majewski M; Wierzbicki P; Składanowski AC; Bigda J
Int J Biochem Cell Biol; 2015 Dec; 69():1-10. PubMed ID: 26545615
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor.
Hart ML; Grenz A; Gorzolla IC; Schittenhelm J; Dalton JH; Eltzschig HK
J Immunol; 2011 Apr; 186(7):4367-74. PubMed ID: 21357264
[TBL] [Abstract][Full Text] [Related]
35. CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection.
Mahamed DA; Toussaint LE; Bynoe MS
Infect Immun; 2015 Feb; 83(2):721-9. PubMed ID: 25452548
[TBL] [Abstract][Full Text] [Related]
36. CD73 regulates vascular smooth muscle cell functions and facilitates atherosclerotic plaque formation.
Yang J; Jian R; Yu J; Zhi X; Liao X; Yu J; Zhou P
IUBMB Life; 2015 Nov; 67(11):853-60. PubMed ID: 26506509
[TBL] [Abstract][Full Text] [Related]
37. Effects of ecto-5'-nucleotidase on human breast cancer cell growth in vitro and in vivo.
Zhou X; Zhi X; Zhou P; Chen S; Zhao F; Shao Z; Ou Z; Yin L
Oncol Rep; 2007 Jun; 17(6):1341-6. PubMed ID: 17487388
[TBL] [Abstract][Full Text] [Related]
38. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5'-nucleotidase/CD73-dependent mechanism.
Henttinen T; Jalkanen S; Yegutkin GG
J Biol Chem; 2003 Jul; 278(27):24888-95. PubMed ID: 12707258
[TBL] [Abstract][Full Text] [Related]
39. CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury.
Ehrentraut H; Clambey ET; McNamee EN; Brodsky KS; Ehrentraut SF; Poth JM; Riegel AK; Westrich JA; Colgan SP; Eltzschig HK
FASEB J; 2013 Jun; 27(6):2207-19. PubMed ID: 23413361
[TBL] [Abstract][Full Text] [Related]
40. CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells.
Ode A; Kopf J; Kurtz A; Schmidt-Bleek K; Schrade P; Kolar P; Buttgereit F; Lehmann K; Hutmacher DW; Duda GN; Kasper G
Eur Cell Mater; 2011 Jul; 22():26-42. PubMed ID: 21732280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
